共 6 条
[1]
Anstee QM(2019)From NASH to HCC: current concepts and future challenges Nat. Rev. Gastroenterol. Hepatol. 16 411-428
[2]
Ringelhan M(2018)The immunology of hepatocellular carcinoma Nat. Immunol. 19 222-232
[3]
Younossi ZM(2019)Non-alcoholic fatty liver disease – a global public health perspective J. Hepatol. 70 531-544
[4]
Lazarus JV(2021)Advancing the global public health agenda for NAFLD: a consensus statement Nat. Rev. Gastroenterol. Hepatol. 13 685-686
[5]
Abdelmalek MF(2016)The clinical and economic burden of NAFLD: time to turn the tide Nat. Rev. Gastroenterol. Hepatol. 18 1592-1599
[6]
Hagström H(2020)Health care costs of patients with biopsy-confirmed nonalcoholic fatty liver disease are nearly twice those of matched controls Clin. Gastroenterol. Hepatol. undefined undefined-undefined